Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Strides Pharma Science Limited
Okres |
2024-03-31 |
2025-03-31 |
2026-03-31 |
2027-03-31 |
2028-03-31 |
Przychód (średnia) |
41,158.50 |
41,158.50 |
46,294.50 |
50,754.00 |
56,875.00 |
Przychód Δ r/r |
0.00% |
0.00% |
12.48% |
9.63% |
12.06% |
Przychód (min) |
40,346.54 |
40,346.54 |
45,862.90 |
50,280.83 |
55,879.87 |
Przychód (max) |
41,970.45 |
41,970.45 |
46,726.10 |
51,227.17 |
57,870.13 |
EBITDA (średnia) |
4,894.73 |
4,921.34 |
5,535.45 |
6,068.68 |
6,800.57 |
EBIT (średnia) |
2,225.45 |
2,433.83 |
2,737.53 |
3,001.24 |
3,363.19 |
EBIT % |
5.41% |
5.91% |
5.91% |
5.91% |
5.91% |
Zysk netto (średni) |
499.07 |
499.51 |
3,276.07 |
4,722.99 |
6,247.00 |
Zysk netto % |
1.21% |
1.21% |
7.08% |
9.31% |
10.98% |
EPS (średnia) |
5.49 |
5.49 |
36.00 |
51.90 |
67.80 |
Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
2 |
Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
2 |
symbol |
STAR.BO |
STAR.BO |
STAR.BO |
STAR.BO |
STAR.BO |